|
Neonatal Intensive Care Drug Manual
|
bet | 348/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
References
|
Chandran S, Haqueb ME, Wickramasinghe HT, Wint Z. Use of magnesium sulphate in severe persistent pulmonary hypertension of the newborn. J Trop Pediatr. 2004;50:219-23.
Daffa SH, Milaat WA. Role of magnesium sulphate in treatment of severe persistent pulmonary hypertension of the neoborn. Saudi Medical Journal. 2002;23:1266-9.
Dehdashtian M, Tebatebae K. Magnesium sulphate as a safe treatment for persistent pulmonary hypertension of newborn resistant to mechanical hyperventilation. Pakistan Journal of Medical Sciences. 2007;23:693-7.
Tolsa JF, Cotting J, Sekarski N, Payot M, Micheli JL, Calame A. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Archives of Disease in Childhood. 1995;72:F184-F7.
Tagin M, Shah PS, Lee KS. Magnesium for newborns with hypoxic-ischemic encephalopathy: A systematic review and meta-analysis. Journal of Perinatology. 2013;33:663-9.
Bhat MA, Charoo BA, Bhat JI, Ahmad SM, Ali SW, Mufti MU. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics. 2009;123:e764-9.
Gathwala G, Khera A, Singh J, Balhara B. Magnesium for neuroprotection in birth asphyxia. Journal of Pediatric Neurosciences. 2010;5:102-4.
Groenendaal F, Rademaker CM, Toet MC, de Vries LS. Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr. 2002;91:1073-7.
Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ, Sumida Y, Takahashi Y, Fujinaga H, Minami H. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatrics International. 2002;44:505-9.
Khashaba MT, Shouman BO, Shaltout AA, Al-Marsafawy HM, Abdel-Aziz MM, Patel K, Aly H. Excitatory amino acids and magnesium sulfate in neonatal asphyxia. Brain Dev. 2006;28:375-9.
Gulczynska E, Gadzinowski J, Walas W, Maczka A, Talar T, Kesiak M, Caputa J, Sobolewska B. Therapeutic hypothermia enhanced by MGSO4 for hypoxic-ischemic encephalopathy in the neonates and its influence on biomarkers of asphyxia and course of hospitalization. Journal of Maternal-Fetal and Neonatal Medicine. 2014;27:221.
Gulczynska EMA, Gadzinowski J, Talar T, Nowiczewski M, Cyranowicz B. Therapeutic hypothermia enhanced by magnesium sulphate for hypoxic-ischemic encephalopathy in the neonates - and their influence on protein S-100B and ceruloplasmin serum concentration. Journal of Maternal-Fetal and Neonatal Medicine. 2012;25:32.
Hossain MM, Mannan MA, Yeasmin F, Shaha CK, Rahman MH, Shahidullah M. Short-term outcome of magnesium sulfate infusion in perinatal asphyxia. Mymensingh medical journal : MMJ. 2013;22:727-35.
Rahman SU, Canpolat FE, Oncel MY, Evli A, Dilmen U, Parappil H, Anabrees J, Hassan K, Khashaba M, Noor IA, Lum LCS, Siham A, Akar M, Tuzun H, Rahmani A, Rahman M, Haboub L, Rijims M, Jaafar R, Key LY, Tagin M. Multicenter randomized controlled trial of therapeutic hypothermia plus magnesium sulfate versus therapeutic hypothermia plus placebo in the management of term and near-term infants with hypoxic ischemic encephalopathy (The Mag Cool study): A pilot study. Journal of Clinical Neonatology. 2015;4:158-63.
ANZCOR Guideline 12.4 – Medications and Fluids in Paediatric Advanced Life Support. https://resus.org.au/wpfb-file/anzcor-guideline-12-4-medications-and-fluids-aug16-pdf/; downloaded 19/04/2018. 2016.
Turner TL, Cockburn F, Forfar JO. Magnesium therapy in neonatal tetany. Lancet. 1977;1:283-4.
Micromedex online. Accessed on 22 March 2016.
|
|
|
| |